Stock

Clearwater Analytics to acquire Enfusion in $1.5 billion deal

(Reuters) -Clearwater Analytics has agreed to acquire investment management platform Enfusion in a $1.5 billion cash-and-stock deal, the companies said on Monday.

Enfusion shareholders will receive $5.85 in cash and $5.40 in Clearwater stock for each share, valuing the company at $11.25 per share, a 13% premium to its last close.

Reuters had exclusively reported last year that Chicago-based firm was exploring options including a sale.

J.P. Morgan Securities and Kirkland & Ellis advised Clearwater Analytics, while Goldman Sachs and Dechert advised Enfusion’s special committee.

This post appeared first on investing.com

Related posts
Stock

China Vanke’s CEO, chairman resign amid growing liquidity worries

(Reuters) – Property developer China Vanke said on Monday its chairman Yu Liang and CEO Zhu Jiusheng had resigned, amid growing concerns…
Stock

Fuji Media, rocked by sexual misconduct allegations, says executives to resign

By Rocky Swift TOKYO (Reuters) -Japan’s Fuji Media said on Monday its chairman and the head of its TV unit would step…
Stock

UMG shares rally after new multi-year pact with Spotify

Investing.com — Universal Music Group (AS:UMG) and Spotify (NYSE:SPOT) have announced a new multi-year deal for recorded music and publishing, the companies…